Botanix Pharmaceuticals Limited’s Acquisition of Sofpironium Bromide

Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal.Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel, 15%,…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now